A: | SECTION A HUMAN NECESSITIES | |
A61: | MEDICAL OR VETERINARY SCIENCE; HYGIENE | |
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | |
A61K6/00: | Preparations for dentistry | |
A61K6/02: | . Use of preparations for artificial teeth, for filling or for capping teeth | |
A61K6/027: | . . Use of non-metallic elements or compounds thereof, e.g. carbon | |
A61K6/033: | . . . Phosphorus compounds, e.g. apatite | |
A61K6/04: | . . Use of metals or alloys | |
A61K6/05: | . . . Amalgams | |
A61K6/06: | . . Use of inorganic cements | |
A61K6/08: | . . Use of natural or synthetic resins | |
A61K6/083: | . . . Compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds | |
A61K6/087: | . . . Compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds | |
A61K6/09: | . . . . Polyurethanes | |
A61K6/093: | . . . . Polyorganosilicon compounds | |
A61K6/097: | . . . Polysaccharides | |
A61K6/10: | . Compositions for taking dental impressions | |
A61K8/00: | Cosmetics or similar toilet preparations | |
A61K8/02: | . characterised by special physical form | |
A61K8/03: | . . Liquid compositions with two or more distinct layers | |
A61K8/04: | . . Dispersions; Emulsions | |
A61K8/06: | . . . Emulsions | |
A61K8/11: | . . Encapsulated compositions | |
A61K8/14: | . . Liposomes | |
A61K8/18: | . characterised by the composition | |
A61K8/19: | . . containing inorganic ingredients | |
A61K8/20: | . . . Halogens; Compounds thereof | |
A61K8/21: | . . . . Fluorides; Derivatives thereof | |
A61K8/22: | . . . Peroxides; Oxygen; Ozone | |
A61K8/23: | . . . Sulfur; Selenium; Tellurium; Compounds thereof | |
A61K8/24: | . . . Phosphorus; Compounds thereof | |
A61K8/25: | . . . Silicon; Compounds thereof | |
A61K8/26: | . . . Aluminium; Compounds thereof | |
A61K8/27: | . . . Zinc; Compounds thereof | |
A61K8/28: | . . . Zirconium; Compounds thereof | |
A61K8/29: | . . . Titanium; Compounds thereof | |
A61K8/30: | . . containing organic compounds | |
A61K8/31: | . . . Hydrocarbons | |
A61K8/33: | . . . containing oxygen | |
A61K8/34: | . . . . Alcohols | |
A61K8/35: | . . . . Ketones, e.g. quinones, benzophenone | |
A61K8/36: | . . . . Carboxylic acids; Salts or anhydrides thereof | |
A61K8/362: | . . . . . Polycarboxylic acids | |
A61K8/365: | . . . . . Hydroxycarboxylic acids; Ketocarboxylic acids | |
A61K8/368: | . . . . . with carboxyl groups directly bound to carbon atoms of aromatic rings | |
A61K8/37: | . . . . Esters of carboxylic acids | |
A61K8/38: | . . . . Percompounds, e.g. peracids | |
A61K8/39: | . . . . Derivatives containing from 2 to 10 oxyalkylene groups | |
A61K8/40: | . . . containing nitrogen | |
A61K8/41: | . . . . Amines | |
A61K8/42: | . . . . Amides | |
A61K8/43: | . . . . Guanidines | |
A61K8/44: | . . . . Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts, esters or N-acylated derivatives thereof | |
A61K8/45: | . . . . Derivatives containing from 2 to 10 oxyalkylene groups | |
A61K8/46: | . . . containing sulfur | |
A61K8/49: | . . . containing heterocyclic compounds | |
A61K8/55: | . . . containing phosphorus | |
A61K8/58: | . . . containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus | |
A61K8/60: | . . . Sugars; Derivatives thereof | |
A61K8/63: | . . . Steroids; Derivatives thereof | |
A61K8/64: | . . . Proteins; Peptides; Derivatives or degradation products thereof | |
A61K8/65: | . . . . Collagen; Gelatin; Keratin; Derivatives or degradation products thereof | |
A61K8/66: | . . . . Enzymes | |
A61K8/67: | . . . Vitamins | |
A61K8/68: | . . . Sphingolipids, e.g. ceramides, cerebrosides, gangliosides | |
A61K8/69: | . . . containing fluorine | |
A61K8/70: | . . . . containing perfluoro groups, e.g. perfluoroethers | |
A61K8/72: | . . containing organic macromolecular compounds | |
A61K8/73: | . . . Polysaccharides | |
A61K8/81: | . . . obtained by reactions involving only carbon-to-carbon unsaturated bonds | |
A61K8/84: | . . . obtained by reactions other than those involving only carbon-to-carbon unsaturated bonds | |
A61K8/85: | . . . . Polyesters | |
A61K8/86: | . . . . Polyethers | |
A61K8/87: | . . . . Polyurethanes | |
A61K8/88: | . . . . Polyamides | |
A61K8/89: | . . . . Polysiloxanes | |
A61K8/891: | . . . . . saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone | |
A61K8/892: | . . . . . . modified by a hydroxy group, e.g. dimethiconol | |
A61K8/893: | . . . . . . modified by an alkoxy or aryloxy group, e.g. behenoxy dimethicone or stearoxy dimethicone | |
A61K8/894: | . . . . . . modified by a polyoxyalkylene group, e.g. cetyl dimethicone copolyol | |
A61K8/895: | . . . . . containing silicon bound to unsaturated aliphatic groups, e.g. vinyl dimethicone | |
A61K8/896: | . . . . . containing atoms other than silicon, carbon, oxygen and hydrogen, e.g. dimethicone copolyol phosphate | |
A61K8/897: | . . . . . . containing halogen, e.g. fluorosilicones | |
A61K8/898: | . . . . . . containing nitrogen, e.g. amodimethicone, trimethyl silyl amodimethicone or dimethicone propyl PG-betaine | |
A61K8/899: | . . . . . . containing sulfur, e.g. sodium PG-propyldimethicone thiosulfate copolyol | |
A61K8/90: | . . . Block copolymers | |
A61K8/91: | . . . Graft copolymers | |
A61K8/92: | . . Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products | |
A61K8/96: | . . containing materials, or derivatives thereof, of undetermined constitution | |
A61K8/97: | . . . from algae, fungi, lichens or plants; from derivatives thereof | |
A61K8/9706: | . . . . Algae | |
A61K8/9711: | . . . . . Phaeophycota or Phaeophyta [brown algae], e.g. Fucus | |
A61K8/9717: | . . . . . Rhodophycota or Rhodophyta [red algae], e.g. Porphyra | |
A61K8/9722: | . . . . . Chlorophycota or Chlorophyta [green algae], e.g. Chlorella | |
A61K8/9728: | . . . . Fungi, e.g. yeasts | |
A61K8/9733: | . . . . Lichens | |
A61K8/9739: | . . . . Bryophyta [mosses] | |
A61K8/9741: | . . . . Pteridophyta [ferns] | |
A61K8/9749: | . . . . . Filicopsida or Pteridopsida | |
A61K8/9755: | . . . . Gymnosperms [Coniferophyta] | |
A61K8/9761: | . . . . . Cupressaceae [Cypress family], e.g. juniper or cypress | |
A61K8/9767: | . . . . . Pinaceae [Pine family], e.g. pine or cedar | |
A61K8/9771: | . . . . Ginkgophyta, e.g. Ginkgoaceae [Ginkgo family] | |
A61K8/9778: | . . . . Gnetophyta, e.g. Ephedraceae [Mormon-tea family] | |
A61K8/9783: | . . . . Angiosperms [Magnoliophyta] | |
A61K8/9789: | . . . . . Magnoliopsida [dicotyledons] | |
A61K8/9794: | . . . . . Liliopsida [monocotyledons] | |
A61K8/98: | . . . of animal origin | |
A61K8/99: | . . . from microorganisms other than algae or fungi, e.g. protozoa or bacteria | |
A61K9/00: | Medicinal preparations characterised by special physical form | |
A61K9/02: | . Suppositories; Bougies; Bases for suppositories or bougies | |
A61K9/06: | . Ointments; Bases therefor | |
A61K9/08: | . Solutions | |
A61K9/10: | . Dispersions; Emulsions | |
A61K9/107: | . . Emulsions | |
A61K9/113: | . . . Multiple emulsions, e.g. oil-in-water-in-oil | |
A61K9/12: | . . Aerosols; Foams | |
A61K9/127: | . . Liposomes | |
A61K9/133: | . . . Unilamellar vesicles | |
A61K9/14: | . Particulate form, e.g. powders | |
A61K9/16: | . . Agglomerates; Granulates; Microbeadlets | |
A61K9/18: | . . Adsorbates | |
A61K9/19: | . . lyophilised | |
A61K9/20: | . Pills, lozenges or tablets | |
A61K9/22: | . . Sustained or differential release type | |
A61K9/24: | . . . Layered or laminated unitary dosage forms | |
A61K9/26: | . . . Discrete particles in supporting matrix | |
A61K9/28: | . . Dragees; Coated pills or tablets | |
A61K9/30: | . . . Organic coatings | |
A61K9/32: | . . . . containing solid synthetic polymers | |
A61K9/34: | . . . . containing natural gums or resins | |
A61K9/36: | . . . . containing carbohydrates or derivatives thereof | |
A61K9/38: | . . . . containing proteins or derivatives thereof | |
A61K9/40: | . . . . . Gelatin containing | |
A61K9/42: | . . . . containing waxes, higher fatty acids, higher fatty alcohols, or derivatives thereof, e.g. chocolate | |
A61K9/44: | . . printed, embossed, grooved, or perforated | |
A61K9/46: | . . effervescent | |
A61K9/48: | . Preparations in capsules, e.g. of gelatin, of chocolate | |
A61K9/50: | . . Microcapsules | |
A61K9/51: | . . . Nanocapsules | |
A61K9/52: | . . Sustained or differential release type | |
A61K9/54: | . . . containing discrete particles with coatings of different thicknesses or different materials | |
A61K9/56: | . . . . Organic coatings | |
A61K9/58: | . . . . . containing solid synthetic polymers | |
A61K9/60: | . . . . . containing natural gums or resins | |
A61K9/62: | . . . . . containing carbohydrates or derivatives thereof | |
A61K9/64: | . . . . . containing proteins or derivatives thereof | |
A61K9/66: | . . . containing emulsions, dispersions or solutions | |
A61K9/68: | . chewing gum type | |
A61K9/70: | . Web, sheet or filament bases | |
A61K9/72: | . for smoking or inhaling | |
A61K31/00: | Medicinal preparations containing organic active ingredients | |
A61K31/01: | . Hydrocarbons | |
A61K31/015: | . . carbocyclic | |
A61K31/02: | . Halogenated hydrocarbons | |
A61K31/025: | . . carbocyclic | |
A61K31/03: | . . . aromatic | |
A61K31/035: | . . having aliphatic unsaturation | |
A61K31/04: | . Nitro compounds | |
A61K31/045: | . Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates | |
A61K31/047: | . . having two or more hydroxy groups, e.g. sorbitol | |
A61K31/05: | . . Phenols | |
A61K31/055: | . . . the aromatic ring being substituted by halogen | |
A61K31/06: | . . . the aromatic ring being substituted by nitro groups | |
A61K31/065: | . . Diphenyl-substituted acyclic alcohols | |
A61K31/07: | . . Retinol compounds, e.g. vitamin A | |
A61K31/075: | . Ethers or acetals | |
A61K31/08: | . . acyclic, e.g. paraformaldehyde | |
A61K31/085: | . . having an ether linkage to aromatic ring nuclear carbon | |
A61K31/09: | . . . having two or more such linkages | |
A61K31/095: | . Sulfur, selenium or tellurium compounds, e.g. thiols | |
A61K31/10: | . . Sulfides; Sulfoxides; Sulfones | |
A61K31/105: | . . Persulfides | |
A61K31/11: | . Aldehydes | |
A61K31/115: | . . Formaldehyde | |
A61K31/12: | . Ketones | |
A61K31/121: | . . acyclic | |
A61K31/122: | . . having the oxygen atom directly attached to a ring, e.g. quinones, vitamin K1, anthralin | |
A61K31/125: | . . . Camphor; Nuclear substituted derivatives thereof | |
A61K31/13: | . Amines, e.g. amantadine | |
A61K31/131: | . . acyclic | |
A61K31/132: | . . having two or more amino groups, e.g. spermidine, putrescine | |
A61K31/133: | . . having hydroxy groups, e.g. sphingosine | |
A61K31/135: | . . having aromatic rings, e.g. methadone | |
A61K31/136: | . . . having the amino group directly attached to the aromatic ring, e.g. benzeneamine | |
A61K31/137: | . . . Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine | |
A61K31/138: | . . . Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine | |
A61K31/14: | . . Quaternary ammonium compounds, e.g. edrophonium, choline | |
A61K31/145: | . . having sulfur atoms, e.g. thiurams (N—C(S)—S—C(S)—N or N—C(S)—S—S—C(S)—N); Sulfinylamines (—N=SO); Sulfonylamines (—N=SO2) | |
A61K31/15: | . . Oximes (C=N—O—); Hydrazines (N—N); Hydrazones (N—N=) | |
A61K31/155: | . . Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (HN=C(OH)NH2), isothiourea (HN=C(SH)—NH2) | |
A61K31/16: | . Amides, e.g. hydroxamic acids | |
A61K31/164: | . . of a carboxylic acid with an aminoalcohol, e.g. ceramides | |
A61K31/165: | . . having aromatic rings, e.g. colchicine, atenolol, progabide | |
A61K31/166: | . . . having the carbon atom of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol | |
A61K31/167: | . . . having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol | |
A61K31/17: | . . having the group N—C(O)—N or N—C(S)—N, e.g. urea, thiourea, carmustine | |
A61K31/175: | . . . having the group , N—C(O)—N=N— or , e.g. carbonohydrazides, carbazones, semicarbazides, semicarbazones; Thioanalogues thereof | |
A61K31/18: | . . Sulfonamides | |
A61K31/185: | . Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids | |
A61K31/19: | . . Carboxylic acids, e.g. valproic acid | |
A61K31/191: | . . . Acyclic acids having two or more hydroxy groups, e.g. gluconic acid | |
A61K31/192: | . . . having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid | |
A61K31/194: | . . . having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid | |
A61K31/195: | . . . having an amino group | |
A61K31/196: | . . . . the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil | |
A61K31/197: | . . . . the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid (GABA), beta-alanine, epsilon-aminocaproic acid, pantothenic acid | |
A61K31/198: | . . . . . Alpha-amino acids, e.g. alanine, edetic acid (EDTA) | |
A61K31/20: | . . . having a carboxyl group bound to an acyclic chain of seven or more carbon atoms, e.g. stearic, palmitic or arachidic acid | |
A61K31/201: | . . . . having one or two double bonds, e.g. oleic or linoleic acid | |
A61K31/202: | . . . . having three or more double bonds, e.g. linolenic acid | |
A61K31/203: | . . . . Retinoic acids | |
A61K31/205: | . . Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine | |
A61K31/21: | . Esters, e.g. nitroglycerine, selenocyanates | |
A61K31/215: | . . of carboxylic acids | |
A61K31/216: | . . . of acids having aromatic rings, e.g. benactizyne, clofibrate | |
A61K31/22: | . . . of acyclic acids, e.g. pravastatin | |
A61K31/221: | . . . . with compounds having an amino group, e.g. acetylcholine, acetylcarnitine | |
A61K31/222: | . . . . with compounds having aromatic groups, e.g. dipivefrine, ibopamine | |
A61K31/223: | . . . . of alpha-amino acids | |
A61K31/225: | . . . . Polycarboxylic acids | |
A61K31/23: | . . . . of acids having a carboxyl group bound to a chain of seven or more carbon atoms | |
A61K31/231: | . . . . . having one or two double bonds | |
A61K31/232: | . . . . . having three or more double bonds, e.g. etretinate | |
A61K31/235: | . . . having an aromatic ring attached to a carboxyl group | |
A61K31/24: | . . . . having an amino or nitro group | |
A61K31/245: | . . . . . Amino benzoic acid types, e.g. procaine, novocaine | |
A61K31/25: | . . . with polyoxyalkylated alcohols, e.g. esters of polyethylene glycol | |
A61K31/255: | . . of sulfoxy acids or sulfur analogues thereof | |
A61K31/26: | . . Cyanate or isocyanate esters; Thiocyanate or isothiocyanate esters | |
A61K31/265: | . . of carbonic, thiocarbonic or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid | |
A61K31/27: | . . of carbamic or thiocarbamic acids, e.g. meprobamate, carbachol, neostigmine | |
A61K31/275: | . Nitriles; Isonitriles | |
A61K31/277: | . . having a ring, e.g. verapamil | |
A61K31/28: | . Compounds containing heavy metals | |
A61K31/282: | . . Platinum compounds | |
A61K31/285: | . . Arsenic compounds | |
A61K31/29: | . . Antimony or bismuth compounds | |
A61K31/295: | . . Iron group metal compounds | |
A61K31/30: | . . Copper compounds | |
A61K31/305: | . . Mercury compounds | |
A61K31/31: | . . . containing nitrogen | |
A61K31/315: | . . Zinc compounds | |
A61K31/32: | . . Tin compounds | |
A61K31/325: | . Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof | |
A61K31/327: | . Peroxy compounds, e.g. hydroperoxides, peroxides, peroxy acids | |
A61K31/33: | . Heterocyclic compounds | |
A61K31/335: | . . having oxygen as the only ring hetero atom, e.g. fungichromin | |
A61K31/336: | . . . having three-membered rings, e.g. oxirane, fumagillin | |
A61K31/337: | . . . having four-membered rings, e.g. taxol | |
A61K31/34: | . . . having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide | |
A61K31/341: | . . . . not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine | |
A61K31/343: | . . . . condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone | |
A61K31/345: | . . . . Nitrofurans | |
A61K31/35: | . . . having six-membered rings with one oxygen as the only ring hetero atom | |
A61K31/351: | . . . . not condensed with another ring | |
A61K31/352: | . . . . condensed with carbocyclic rings, e.g. cannabinols, methantheline | |
A61K31/353: | . . . . . 3,4-Dihydrobenzopyrans, e.g. chroman, catechin | |
A61K31/355: | . . . . . . Tocopherols, e.g. vitamin E | |
A61K31/357: | . . . having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel | |
A61K31/36: | . . . . Compounds containing methylenedioxyphenyl groups, e.g. sesamin | |
A61K31/365: | . . . Lactones | |
A61K31/366: | . . . . having six-membered rings, e.g. delta-lactones | |
A61K31/37: | . . . . . Coumarins, e.g. psoralen | |
A61K31/375: | . . . . Ascorbic acid, i.e. vitamin C; Salts thereof | |
A61K31/38: | . . having sulfur as a ring hetero atom | |
A61K31/381: | . . . having five-membered rings | |
A61K31/382: | . . . having six-membered rings, e.g. thioxanthenes | |
A61K31/385: | . . . having two or more sulfur atoms in the same ring | |
A61K31/39: | . . . having oxygen atoms in the same ring | |
A61K31/395: | . . having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins | |
A61K31/396: | . . . having three-membered rings, e.g. aziridine | |
A61K31/397: | . . . having four-membered rings, e.g. azetidine | |
A61K31/40: | . . . having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil | |
A61K31/401: | . . . . Proline; Derivatives thereof, e.g. captopril | |
A61K31/4015: | . . . . having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide | |
A61K31/402: | . . . . 1-aryl-substituted, e.g. piretanide | |
A61K31/4025: | . . . . not condensed and containing further heterocyclic rings, e.g. cromakalim | |
A61K31/403: | . . . . condensed with carbocyclic rings, e.g. carbazole | |
A61K31/4035: | . . . . . Isoindoles, e.g. phthalimide | |
A61K31/404: | . . . . . Indoles, e.g. pindolol | |
A61K31/4045: | . . . . . . Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin | |
A61K31/405: | . . . . . . Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin | |
A61K31/407: | . . . . condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine | |
A61K31/409: | . . . . having four such rings, e.g. porphine derivatives, bilirubin, biliverdine | |
A61K31/41: | . . . having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole | |
A61K31/415: | . . . . 1,2-Diazoles | |
A61K31/4152: | . . . . . having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone | |
A61K31/4155: | . . . . . not condensed and containing further heterocyclic rings | |
A61K31/416: | . . . . . condensed with carbocyclic ring systems, e.g. indazole | |
A61K31/4162: | . . . . . condensed with heterocyclic ring systems | |
A61K31/4164: | . . . . 1,3-Diazoles | |
A61K31/4166: | . . . . . having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin | |
A61K31/4168: | . . . . . having a nitrogen atom attached in position 2, e.g. clonidine | |
A61K31/417: | . . . . . Imidazole-alkylamines, e.g. histamine, phentolamine | |
A61K31/4172: | . . . . . Imidazole-alkanecarboxylic acids, e.g. histidine | |
A61K31/4174: | . . . . . Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole | |
A61K31/4178: | . . . . . not condensed and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin | |
A61K31/4184: | . . . . . condensed with carbocyclic rings, e.g. benzimidazoles | |
A61K31/4188: | . . . . . condensed with heterocyclic ring systems, e.g. biotin, sorbinil | |
A61K31/4192: | . . . . 1,2,3-Triazoles | |
A61K31/4196: | . . . . 1,2,4-Triazoles | |
A61K31/42: | . . . . Oxazoles | |
A61K31/421: | . . . . . 1,3-Oxazoles, e.g. pemoline, trimethadione | |
A61K31/422: | . . . . . not condensed and containing further heterocyclic rings | |
A61K31/423: | . . . . . condensed with carbocyclic rings | |
A61K31/424: | . . . . . condensed with heterocyclic ring systems, e.g. clavulanic acid | |
A61K31/4245: | . . . . Oxadiazoles | |
A61K31/425: | . . . . Thiazoles | |
A61K31/426: | . . . . . 1,3-Thiazoles | |
A61K31/427: | . . . . . not condensed and containing further heterocyclic rings | |
A61K31/428: | . . . . . condensed with carbocyclic rings | |
A61K31/429: | . . . . . condensed with heterocyclic ring systems | |
A61K31/43: | . . . . . . Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula , e.g. penicillins, penems | |
A61K31/431: | containing further heterocyclic ring systems, e.g. ticarcillin, azlocillin, oxacillin | |
A61K31/433: | . . . . Thiadiazoles | |
A61K31/435: | . . . having six-membered rings with one nitrogen as the only ring hetero atom | |
A61K31/4353: | . . . . ortho- or peri-condensed with heterocyclic ring systems | |
A61K31/4355: | . . . . . the heterocyclic ring system containing a five-membered ring having oxygen as a ring hetero atom | |
A61K31/436: | . . . . . the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin | |
A61K31/4365: | . . . . . the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine | |
A61K31/437: | . . . . . the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline | |
A61K31/4375: | . . . . . the heterocyclic ring system containing a six-membered ring having nitrogen as a ring hetero atom, e.g. quinolizines, naphthyridines, berberine, vincamine | |
A61K31/438: | . . . . the ring being spiro-condensed with carbocyclic or heterocyclic ring systems | |
A61K31/439: | . . . . the ring forming part of a bridged ring system, e.g. quinuclidine | |
A61K31/44: | . . . . Non-condensed pyridines; Hydrogenated derivatives thereof | |
A61K31/4402: | . . . . . only substituted in position 2, e.g. pheniramine, bisacodyl | |
A61K31/4406: | . . . . . only substituted in position 3, e.g. zimeldine | |
A61K31/4409: | . . . . . only substituted in position 4, e.g. isoniazid, iproniazid | |
A61K31/4412: | . . . . . having oxo groups directly attached to the heterocyclic ring | |
A61K31/4415: | . . . . . Pyridoxine, i.e.vitamin B6 | |
A61K31/4418: | . . . . . having a carbocyclic ring directly attached to the heterocyclic ring, e.g. cyproheptadine | |
A61K31/4422: | . . . . . 1,4-Dihydropyridines, e.g. nifedipine, nicardipine | |
A61K31/4425: | . . . . . Pyridinium derivatives, e.g. pralidoxime, pyridostigmine | |
A61K31/4427: | . . . . . containing further heterocyclic ring systems | |
A61K31/443: | . . . . . . containing a five-membered ring with oxygen as a ring hetero atom | |
A61K31/4433: | . . . . . . containing a six-membered ring with oxygen as a ring hetero atom | |
A61K31/4436: | . . . . . . containing a heterocyclic ring having sulfur as a ring hetero atom | |
A61K31/4439: | . . . . . . containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole | |
A61K31/444: | . . . . . . containing a six-membered ring with nitrogen as a ring hetero atom, e.g. amrinone | |
A61K31/445: | . . . . . Non-condensed piperidines, e.g. piperocaine | |
A61K31/4453: | . . . . . . only substituted in position 1, e.g. propipocaine, diperodon | |
A61K31/4458: | . . . . . . only substituted in position 2, e.g. methylphenidate | |
A61K31/4462: | . . . . . . only substituted in position 3 | |
A61K31/4465: | . . . . . . only substituted in position 4 | |
A61K31/4468: | . . . . . . having a nitrogen atom directly attached in position 4, e.g. clebopride, fentanyl | |
A61K31/45: | . . . . . . having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide | |
A61K31/451: | . . . . . . having a carbocyclic ring directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine | |
A61K31/4515: | . . . . . . having a butyrophenone group in position 1, e.g. haloperidol | |
A61K31/452: | . . . . . . Piperidinium derivatives | |
A61K31/4523: | . . . . . . containing further heterocyclic ring systems | |
A61K31/4525: | containing a five-membered ring with oxygen as a ring hetero atom | |
A61K31/453: | containing a six-membered ring with oxygen as a ring hetero atom | |
A61K31/4535: | containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen | |
A61K31/454: | containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone | |
A61K31/4545: | containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine | |
A61K31/455: | . . . . . Nicotinic acid, i.e. niacin; Derivatives thereof, e.g. esters, amides | |
A61K31/46: | . . . . 8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine | |
A61K31/465: | . . . . Nicotine; Derivatives thereof | |
A61K31/47: | . . . . Quinolines; Isoquinolines | |
A61K31/4704: | . . . . . 2-Quinolinones, e.g. carbostyril | |
A61K31/4706: | . . . . . 4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine | |
A61K31/4709: | . . . . . Non-condensed quinolines containing further heterocyclic rings | |
A61K31/472: | . . . . . Non-condensed isoquinolines, e.g. papaverine | |
A61K31/4725: | . . . . . . containing further heterocyclic rings | |
A61K31/473: | . . . . . ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines | |
A61K31/4738: | . . . . . ortho- or peri-condensed with heterocyclic ring systems | |
A61K31/4741: | . . . . . . condensed with ring systems having oxygen as a ring hetero atom, e.g. tubocuraran derivatives, noscapine, bicuculline | |
A61K31/4743: | . . . . . . condensed with ring systems having sulfur as a ring hetero atom | |
A61K31/4745: | . . . . . . condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenanthrolines | |
A61K31/4747: | . . . . . spiro-condensed | |
A61K31/4748: | . . . . . forming part of bridged ring systems | |
A61K31/475: | . . . . . having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine | |
A61K31/48: | . . . . . Ergoline derivatives, e.g. lysergic acid, ergotamine | |
A61K31/485: | . . . . . Morphinan derivatives, e.g. morphine, codeine | |
A61K31/49: | . . . . . Cinchonan derivatives, e.g. quinine | |
A61K31/495: | . . . having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine | |
A61K31/496: | . . . . Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene | |
A61K31/4965: | . . . . Non-condensed pyrazines | |
A61K31/497: | . . . . . containing further heterocyclic rings | |
A61K31/498: | . . . . Pyrazines or piperazines ortho- or peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine | |
A61K31/4985: | . . . . Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems | |
A61K31/499: | . . . . Spiro-condensed pyrazines or piperazines | |
A61K31/4995: | . . . . Pyrazines or piperazines forming part of bridged ring systems | |
A61K31/50: | . . . . Pyridazines; Hydrogenated pyridazines | |
A61K31/501: | . . . . . not condensed and containing further heterocyclic rings | |
A61K31/502: | . . . . . ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine | |
A61K31/5025: | . . . . . ortho- or peri-condensed with heterocyclic ring systems | |
A61K31/503: | . . . . . spiro-condensed | |
A61K31/504: | . . . . . forming part of bridged ring systems | |
A61K31/505: | . . . . Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim | |
A61K31/506: | . . . . . not condensed and containing further heterocyclic rings | |
A61K31/51: | . . . . . . Thiamines, e.g. vitamin B1 | |
A61K31/513: | . . . . . having oxo groups directly attached to the heterocyclic ring, e.g. cytosine | |
A61K31/515: | . . . . . . Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital | |
A61K31/517: | . . . . . ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine | |
A61K31/519: | . . . . . ortho- or peri-condensed with heterocyclic rings | |
A61K31/52: | . . . . . . Purines, e.g. adenine | |
A61K31/522: | having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir | |
A61K31/525: | . . . . . . Isoalloxazines, e.g. riboflavins, vitamin B2 | |
A61K31/527: | . . . . . spiro-condensed | |
A61K31/529: | . . . . . forming part of bridged ring systems | |
A61K31/53: | . . . having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine | |
A61K31/535: | . . . having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines | |
A61K31/5355: | . . . . Non-condensed oxazines containing further heterocyclic rings | |
A61K31/536: | . . . . ortho- or peri-condensed with carbocyclic ring systems | |
A61K31/5365: | . . . . ortho- or peri-condensed with heterocyclic ring systems | |
A61K31/537: | . . . . spiro-condensed or forming part of bridged ring systems | |
A61K31/5375: | . . . . 1,4-Oxazines, e.g. morpholine | |
A61K31/5377: | . . . . . not condensed and containing further heterocyclic rings, e.g. timolol | |
A61K31/538: | . . . . . ortho- or peri-condensed with carbocyclic ring systems | |
A61K31/5383: | . . . . . ortho- or peri-condensed with heterocyclic ring systems | |
A61K31/5386: | . . . . . spiro-condensed or forming part of bridged ring systems | |
A61K31/539: | . . . . having two or more oxygen atoms in the same ring, e.g dioxazines | |
A61K31/5395: | . . . . having two or more nitrogen atoms in the same ring, e.g. oxadiazines | |
A61K31/54: | . . . having six-membered rings with at least one nitrogen and at least one sulfur as the ring hetero atoms, e.g. sulthiame | |
A61K31/541: | . . . . Non-condensed thiazines containing further heterocyclic rings | |
A61K31/5415: | . . . . ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam | |
A61K31/542: | . . . . ortho- or peri-condensed with heterocyclic ring systems | |
A61K31/545: | . . . . . Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula , e.g. cephalosporins, cefaclor, cephalexine | |
A61K31/546: | . . . . . . containing further heterocyclic rings, e.g. cephalothin | |
A61K31/547: | . . . . spiro-condensed or forming part of bridged ring systems | |
A61K31/548: | . . . . having two or more sulfur atoms in the same ring | |
A61K31/549: | . . . . having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide | |
A61K31/55: | . . . having seven-membered rings, e.g. azelastine, pentylenetetrazole | |
A61K31/551: | . . . . having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep | |
A61K31/5513: | . . . . . 1,4-Benzodiazepines, e.g. diazepam | |
A61K31/5517: | . . . . . . condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam | |
A61K31/553: | . . . . having at least one nitrogen and at least one oxygen as ring hetero atoms, e.g. loxapine, staurosporine | |
A61K31/554: | . . . . having at least one nitrogen and at least one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem | |
A61K31/555: | . . containing heavy metals, e.g. hemin, hematin, melarsoprol | |
A61K31/557: | . Eicosanoids, e.g. leukotrienes | |
A61K31/5575: | . . having a cyclopentane ring, e.g. prostaglandin E2, prostaglandin F2-alpha | |
A61K31/5578: | . . having a pentalene ring system, e.g. carbacyclin, iloprost | |
A61K31/558: | . . having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes | |
A61K31/5585: | . . . having five-membered rings containing oxygen as the only ring hetero atom, e.g. prostacyclin | |
A61K31/559: | . . having heterocyclic rings containing hetero atoms other than oxygen | |
A61K31/56: | . Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids | |
A61K31/565: | . . not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol | |
A61K31/566: | . . . having an oxo group in position 17, e.g. oestrone | |
A61K31/567: | . . . substituted in position 17 alpha, e.g. mestranol, norethandrolone | |
A61K31/568: | . . . substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstane, testosterone | |
A61K31/5685: | . . . . having an oxo group in position 17, e.g. androsterone | |
A61K31/569: | . . . . substituted in position 17 alpha, e.g. ethisterone | |
A61K31/57: | . . substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone | |
A61K31/573: | . . . substituted in position 21, e.g. cortisone, dexamethasone, prednisone | |
A61K31/575: | . . substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol | |
A61K31/58: | . . containing heterocyclic rings, e.g. aldosterone, danazol, stanozolol, pancuronium, digitogenin | |
A61K31/585: | . . . containing lactone rings, e.g. oxandrolone, bufalin | |
A61K31/59: | . Compounds containing 9,10-seco-cyclopenta[a]hydro- phenanthrene ring systems | |
A61K31/592: | . . 9,10-Secoergostane derivatives, e.g. ergocalciferol, vitamin D2 | |
A61K31/593: | . . 9,10-Secocholestane derivatives, e.g. cholecalciferol, vitamin D3 | |
A61K31/60: | . Salicylic acid; Derivatives thereof | |
A61K31/603: | . . having further aromatic rings, e.g. diflunisal | |
A61K31/606: | . . having amino groups | |
A61K31/609: | . . Amides, e.g. salicylamide | |
A61K31/612: | . . having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid | |
A61K31/616: | . . . by carboxylic acids, e.g. acetylsalicylic acid | |
A61K31/618: | . . having the carboxyl group in position 1 esterified, e.g. salsalate | |
A61K31/621: | . . . having the hydroxy group in position 2 esterified, e.g. benorylate | |
A61K31/625: | . . having heterocyclic substituents, e.g. 4-salicyloylmorpholine | |
A61K31/63: | . Compounds containing para-N-benzene- sulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonohydrazide | |
A61K31/635: | . . having a heterocyclic ring, e.g. sulfadiazine | |
A61K31/64: | . Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide | |
A61K31/65: | . Tetracyclines | |
A61K31/655: | . Azo (—N=N—), diazo (=N2), azoxy (N—O—N or N(=O)—N), azido (—N3) or diazoamino (—N=N—N) compounds | |
A61K31/66: | . Phosphorus compounds | |
A61K31/661: | . . Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion | |
A61K31/6615: | . . . Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid | |
A61K31/662: | . . Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon | |
A61K31/663: | . . . Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid | |
A61K31/664: | . . Amides of phosphorus acids | |
A61K31/665: | . . having oxygen as a ring hetero atom, e.g. fosfomycin | |
A61K31/67: | . . having sulfur as a ring hetero atom | |
A61K31/675: | . . having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate | |
A61K31/683: | . . Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols | |
A61K31/685: | . . . one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin | |
A61K31/688: | . . . both hydroxy compounds having nitrogen atoms, e.g. sphingomyelins | |
A61K31/69: | . Boron compounds | |
A61K31/695: | . Silicon compounds | |
A61K31/70: | . Carbohydrates; Sugars; Derivatives thereof | |
A61K31/7004: | . . Monosaccharides having only carbon, hydrogen and oxygen atoms | |
A61K31/7008: | . . Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine | |
A61K31/7012: | . . Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid | |
A61K31/7016: | . . Disaccharides, e.g. lactose, lactulose | |
A61K31/702: | . . Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages | |
A61K31/7024: | . . Esters of saccharides | |
A61K31/7028: | . . Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages | |
A61K31/7032: | . . . attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyl-diacylglycerides, lactobionic acid, gangliosides | |
A61K31/7034: | . . . attached to a carbocyclic compound, e.g. phloridzin | |
A61K31/7036: | . . . . having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins | |
A61K31/704: | . . . . attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin, digitoxin | |
A61K31/7042: | . . Compounds having saccharide radicals and heterocyclic rings | |
A61K31/7048: | . . . having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin | |
A61K31/7052: | . . . having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides | |
A61K31/7056: | . . . . containing five-membered rings with nitrogen as a ring hetero atom | |
A61K31/706: | . . . . containing six-membered rings with nitrogen as a ring hetero atom | |
A61K31/7064: | . . . . . containing condensed or non-condensed pyrimidines | |
A61K31/7068: | . . . . . . having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid | |
A61K31/7072: | having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine | |
A61K31/7076: | . . . . . . containing purines, e.g. adenosine, adenylic acid | |
A61K31/708: | having oxo groups directly attached to the purine ring system, e.g. guanosine, guanylic acid | |
A61K31/7084: | . . Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide | |
A61K31/7088: | . . Compounds having three or more nucleosides or nucleotides | |
A61K31/7105: | . . . Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links | |
A61K31/711: | . . . Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links | |
A61K31/7115: | . . . Nucleic acids or oligonucleotides having modified bases, i.e. other than adenine, guanine, cytosine, uracil or thymine | |
A61K31/712: | . . . Nucleic acids or oligonucleotides having modified sugars, i.e. other than ribose or 2'-deoxyribose | |
A61K31/7125: | . . . Nucleic acids or oligonucleotides having modified internucleoside linkage, i.e. other than 3'-5' phosphodiesters | |
A61K31/713: | . . . Double-stranded nucleic acids or oligonucleotides | |
A61K31/7135: | . . Compounds containing heavy metals | |
A61K31/714: | . . . Cobalamins, e.g. cyanocobalamin, vitamin B12 | |
A61K31/715: | . . Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters | |
A61K31/716: | . . . Glucans | |
A61K31/717: | . . . . Celluloses | |
A61K31/718: | . . . . Starch or degraded starch, e.g. amylose, amylopectin | |
A61K31/719: | . . . . Pullulans | |
A61K31/721: | . . . . Dextrans | |
A61K31/722: | . . . . Chitin; Chitosan | |
A61K31/723: | . . . . Xanthans | |
A61K31/724: | . . . . Cyclodextrins | |
A61K31/726: | . . . Glycosaminoglycans, i.e. mucopolysaccharides | |
A61K31/727: | . . . . Heparin; Heparan | |
A61K31/728: | . . . . Hyaluronic acid | |
A61K31/729: | . . . Agar; Agarose; Agaropectin | |
A61K31/731: | . . . Carrageenans | |
A61K31/732: | . . . Pectin | |
A61K31/733: | . . . Fructosans, e.g. inulin | |
A61K31/734: | . . . Alginic acid | |
A61K31/736: | . . . Glucomannans or galactomannans, e.g locust bean gum, guar gum | |
A61K31/737: | . . . Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate | |
A61K31/738: | . . . Cross-linked polysaccharides | |
A61K31/739: | . . . Lipopolysaccharides | |
A61K31/74: | . Synthetic polymeric materials | |
A61K31/745: | . . Polymers of hydrocarbons | |
A61K31/75: | . . . of ethene | |
A61K31/755: | . . Polymers containing halogen | |
A61K31/76: | . . . of vinyl chloride | |
A61K31/765: | . . Polymers containing oxygen | |
A61K31/77: | . . . of oxiranes | |
A61K31/775: | . . . Phenolic resins | |
A61K31/78: | . . . of acrylic acid or derivatives thereof | |
A61K31/785: | . . Polymers containing nitrogen | |
A61K31/787: | . . . containing heterocyclic rings having nitrogen as a ring hetero atom | |
A61K31/79: | . . . . Polymers of vinyl pyrrolidone | |
A61K31/795: | . . Polymers containing sulfur | |
A61K31/80: | . . Polymers containing hetero atoms not provided for in groups | |
A61K33/00: | Medicinal preparations containing inorganic active ingredients | |
A61K33/02: | . Ammonia; Compounds thereof | |
A61K33/04: | . Sulfur, selenium or tellurium; Compounds thereof | |
A61K33/06: | . Aluminium, calcium or magnesium; Compounds thereof | |
A61K33/08: | . . Oxides; Hydroxides | |
A61K33/10: | . . Carbonates; Bicarbonates | |
A61K33/12: | . . Magnesium silicate | |
A61K33/14: | . Alkali metal chlorides; Alkaline earth metal chlorides | |
A61K33/16: | . Fluorine compounds | |
A61K33/18: | . Iodine; Compounds thereof | |
A61K33/20: | . Elemental chlorine; Inorganic compounds releasing chlorine | |
A61K33/22: | . Boron compounds | |
A61K33/24: | . Heavy metals; Compounds thereof | |
A61K33/26: | . . Iron; Compounds thereof | |
A61K33/28: | . . Mercury; Compounds thereof | |
A61K33/30: | . . Zinc; Compounds thereof | |
A61K33/32: | . . Manganese; Compounds thereof | |
A61K33/34: | . . Copper; Compounds thereof | |
A61K33/36: | . . Arsenic; Compounds thereof | |
A61K33/38: | . . Silver; Compounds thereof | |
A61K33/40: | . Peroxides | |
A61K33/42: | . Phosphorus; Compounds thereof | |
A61K33/44: | . Elemental carbon, e.g. charcoal, carbon black | |
A61K35/00: | Medicinal preparations containing materials or reaction products thereof with undetermined constitution | |
A61K35/02: | . from inanimate materials | |
A61K35/04: | . . Tars; Bitumens; Mineral oils; Ammonium bituminosulfonate | |
A61K35/06: | . . . Mineral oils, e.g. paraffinic oils or aromatic oils based on aromatic hydrocarbons | |
A61K35/08: | . . Mineral waters; Seawater | |
A61K35/10: | . . Peat; Amber; Turf; Humus | |
A61K35/12: | . Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells | |
A61K35/13: | . . Tumour cells, irrespective of tissue of origin | |
A61K35/14: | . . Blood; Artificial blood | |
A61K35/15: | . . . Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells | |
A61K35/16: | . . . Blood plasma; Blood serum | |
A61K35/17: | . . . Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes | |
A61K35/18: | . . . Erythrocytes | |
A61K35/19: | . . . Platelets; Megacaryocytes | |
A61K35/20: | . . Milk; Whey; Colostrum | |
A61K35/22: | . . Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland | |
A61K35/23: | . . . Kidney | |
A61K35/24: | . . Mucus; Mucous glands; Bursa; Synovial fluid; Arthral fluid; Excreta; Spinal fluid | |
A61K35/26: | . . Lymph; Lymph nodes; Thymus; Spleen; Splenocytes; Thymocytes | |
A61K35/28: | . . Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells | |
A61K35/30: | . . Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue | |
A61K35/32: | . . Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane | |
A61K35/33: | . . Fibroblasts | |
A61K35/34: | . . Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes | |
A61K35/35: | . . Fat tissue; Adipocytes; Stromal cells; Connective tissues | |
A61K35/36: | . . Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells | |
A61K35/37: | . . Digestive system | |
A61K35/38: | . . . Stomach; Intestine; Goblet cells; Oral mucosa; Saliva | |
A61K35/39: | . . . Pancreas; Islets of Langerhans | |
A61K35/407: | . . . Liver; Hepatocytes | |
A61K35/413: | . . . Gall bladder; Bile | |
A61K35/42: | . . Respiratory system, e.g. lungs, bronchi or lung cells | |
A61K35/44: | . . Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells | |
A61K35/48: | . . Reproductive organs | |
A61K35/50: | . . . Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells | |
A61K35/51: | . . . Umbilical cord; Umbilical cord blood; Umbilical stem cells | |
A61K35/52: | . . . Sperm; Prostate; Seminal fluid; Leydig cells of testes | |
A61K35/54: | . . . Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells | |
A61K35/545: | . . . . Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells | |
A61K35/55: | . . Glands not provided for in groups , e.g. thyroids, parathyroids or pineal glands | |
A61K35/56: | . Materials from animals other than mammals | |
A61K35/57: | . . Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli | |
A61K35/58: | . . Reptiles | |
A61K35/583: | . . . Snakes; Lizards, e.g. chameleons | |
A61K35/586: | . . . Turtles; Tortoises, e.g. terrapins | |
A61K35/60: | . . Fish, e.g. seahorses; Fish eggs | |
A61K35/612: | . . Crustaceans, e.g. crabs, lobsters, shrimps, krill or crayfish; Barnacles | |
A61K35/614: | . . Cnidaria, e.g. sea anemones, corals, coral animals or jellyfish | |
A61K35/616: | . . Echinodermata, e.g. starfish, sea cucumbers or sea urchins | |
A61K35/618: | . . Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs | |
A61K35/62: | . . Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia | |
A61K35/63: | . . Arthropods | |
A61K35/64: | . . . Insects, e.g. bees, wasps or fleas | |
A61K35/644: | . . . . Beeswax; Propolis; Royal jelly; Honey | |
A61K35/646: | . . . Arachnids, e.g. spiders, scorpions, ticks or mites | |
A61K35/648: | . . . Myriapods, e.g. centipedes or millipedes | |
A61K35/65: | . . Amphibians, e.g. toads, frogs, salamanders or newts | |
A61K35/655: | . . Aquatic animals other than those covered by groups | |
A61K35/66: | . Microorganisms or materials therefrom | |
A61K35/68: | . . Protozoa, e.g. flagella, amoebas, sporozoans, plasmodium or toxoplasma | |
A61K35/74: | . . Bacteria | |
A61K35/741: | . . . Probiotics | |
A61K35/742: | . . . . Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes | |
A61K35/744: | . . . . Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs | |
A61K35/745: | . . . . . Bifidobacteria | |
A61K35/747: | . . . . . Lactobacilli, e.g. L. acidophilus or L. brevis | |
A61K35/748: | . . . Cyanobacteria, i.e. blue-green bacteria or blue-green algae, e.g. spirulina | |
A61K35/76: | . . Viruses; Subviral particles; Bacteriophages | |
A61K35/761: | . . . Adenovirus | |
A61K35/763: | . . . Herpes virus | |
A61K35/765: | . . . Reovirus; Rotavirus | |
A61K35/766: | . . . Rhabdovirus, e.g. vesicular stomatitis virus | |
A61K35/768: | . . . Oncolytic viruses not provided for in groups | |
A61K36/00: | Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines | |
A61K36/02: | . Algae | |
A61K36/03: | . . Phaeophycota or phaeophyta (brown algae), e.g. Fucus | |
A61K36/04: | . . Rhodophycota or rhodophyta (red algae), e.g. Porphyra | |
A61K36/05: | . . Chlorophycota or chlorophyta (green algae), e.g. Chlorella | |
A61K36/06: | . Fungi, e.g. yeasts | |
A61K36/062: | . . Ascomycota | |
A61K36/064: | . . . Saccharomycetales, e.g. baker's yeast | |
A61K36/066: | . . . Clavicipitaceae | |
A61K36/068: | . . . . Cordyceps | |
A61K36/07: | . . Basidiomycota, e.g. Cryptococcus | |
A61K36/074: | . . . Ganoderma | |
A61K36/076: | . . . Poria | |
A61K36/09: | . Lichens | |
A61K36/10: | . Bryophyta (mosses) | |
A61K36/11: | . Pteridophyta or Filicophyta (ferns) | |
A61K36/12: | . . Filicopsida or Pteridopsida | |
A61K36/126: | . . . Drynaria | |
A61K36/13: | . Coniferophyta (gymnosperms) | |
A61K36/14: | . . Cupressaceae (Cypress family), e.g. juniper or cypress | |
A61K36/15: | . . Pinaceae (Pine family), e.g. pine or cedar | |
A61K36/16: | . Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family) | |
A61K36/17: | . Gnetophyta, e.g. Ephedraceae (Mormon-tea family) | |
A61K36/18: | . Magnoliophyta (angiosperms) | |
A61K36/185: | . . Magnoliopsida (dicotyledons) | |
A61K36/19: | . . . Acanthaceae (Acanthus family) | |
A61K36/195: | . . . . Strobilanthes | |
A61K36/20: | . . . Aceraceae (Maple family) | |
A61K36/21: | . . . Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth | |
A61K36/22: | . . . Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak | |
A61K36/23: | . . . Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin | |
A61K36/232: | . . . . Angelica | |
A61K36/233: | . . . . Bupleurum | |
A61K36/234: | . . . . Cnidium (snowparsley) | |
A61K36/235: | . . . . Foeniculum (fennel) | |
A61K36/236: | . . . . Ligusticum (licorice-root) | |
A61K36/237: | . . . . Notopterygium | |
A61K36/238: | . . . . Saposhnikovia | |
A61K36/24: | . . . Apocynaceae (Dogbane family), e.g. plumeria or periwinkle | |
A61K36/25: | . . . Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax | |
A61K36/254: | . . . . Acanthopanax or Eleutherococcus | |
A61K36/258: | . . . . Panax (ginseng) | |
A61K36/26: | . . . Aristolochiaceae (Birthwort family), e.g. heartleaf | |
A61K36/264: | . . . . Aristolochia (Dutchman's pipe) | |
A61K36/268: | . . . . Asarum (wild ginger) | |
A61K36/27: | . . . Asclepiadaceae (Milkweed family), e.g. hoya | |
A61K36/28: | . . . Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea | |
A61K36/282: | . . . . Artemisia, e.g. wormwood or sagebrush | |
A61K36/284: | . . . . Atractylodes | |
A61K36/285: | . . . . Aucklandia | |
A61K36/286: | . . . . Carthamus (distaff thistle) | |
A61K36/287: | . . . . Chrysanthemum, e.g. daisy | |
A61K36/288: | . . . . Taraxacum (dandelion) | |
A61K36/289: | . . . . Vladimiria | |
A61K36/29: | . . . Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple | |
A61K36/296: | . . . . Epimedium | |
A61K36/30: | . . . Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not | |
A61K36/31: | . . . Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi | |
A61K36/315: | . . . . Isatis, e.g. Dyer's woad | |
A61K36/32: | . . . Burseraceae (Frankincense family) | |
A61K36/324: | . . . . Boswellia, e.g. frankincense | |
A61K36/328: | . . . . Commiphora, e.g. mecca myrrh or balm of Gilead | |
A61K36/33: | . . . Cactaceae (Cactus family), e.g. pricklypear or Cereus | |
A61K36/34: | . . . Campanulaceae (Bellflower family) | |
A61K36/342: | . . . . Adenophora | |
A61K36/344: | . . . . Codonopsis | |
A61K36/346: | . . . . Platycodon | |
A61K36/35: | . . . Caprifoliaceae (Honeysuckle family) | |
A61K36/355: | . . . . Lonicera (honeysuckle) | |
A61K36/36: | . . . Caryophyllaceae (Pink family), e.g. babysbreath or soapwort | |
A61K36/37: | . . . Celastraceae (Staff-tree or Bittersweet family), e.g. tripterygium or spindletree | |
A61K36/38: | . . . Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort | |
A61K36/39: | . . . Convolvulaceae (Morning-glory family), e.g. bindweed | |
A61K36/40: | . . . Cornaceae (Dogwood family) | |
A61K36/41: | . . . Crassulaceae (Stonecrop family) | |
A61K36/42: | . . . Cucurbitaceae (Cucumber family) | |
A61K36/424: | . . . . Gynostemma | |
A61K36/428: | . . . . Trichosanthes | |
A61K36/43: | . . . Cuscutaceae (Dodder family), e.g. Cuscuta epithymum or greater dodder | |
A61K36/44: | . . . Ebenaceae (Ebony family), e.g. persimmon | |
A61K36/45: | . . . Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry | |
A61K36/46: | . . . Eucommiaceae (Eucommia family), e.g. hardy rubber tree | |
A61K36/47: | . . . Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean) | |
A61K36/48: | . . . Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae | |
A61K36/481: | . . . . Astragalus (milkvetch) | |
A61K36/482: | . . . . Cassia, e.g. golden shower tree | |
A61K36/483: | . . . . Gleditsia (locust) | |
A61K36/484: | . . . . Glycyrrhiza (licorice) | |
A61K36/485: | . . . . Gueldenstaedtia | |
A61K36/486: | . . . . Millettia | |
A61K36/487: | . . . . Psoralea | |
A61K36/488: | . . . . Pueraria (kudzu) | |
A61K36/489: | . . . . Sophora, e.g. necklacepod or mamani | |
A61K36/49: | . . . Fagaceae (Beech family), e.g. oak or chestnut | |
A61K36/50: | . . . Fumariaceae (Fumitory family), e.g. bleeding heart | |
A61K36/505: | . . . . Corydalis | |
A61K36/51: | . . . Gentianaceae (Gentian family) | |
A61K36/515: | . . . . Gentiana | |
A61K36/52: | . . . Juglandaceae (Walnut family) | |
A61K36/53: | . . . Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender | |
A61K36/532: | . . . . Agastache, e.g. giant hyssop | |
A61K36/533: | . . . . Leonurus (motherwort) | |
A61K36/534: | . . . . Mentha (mint) | |
A61K36/535: | . . . . Perilla (beefsteak plant) | |
A61K36/536: | . . . . Prunella or Brunella (selfheal) | |
A61K36/537: | . . . . Salvia (sage) | |
A61K36/538: | . . . . Schizonepeta | |
A61K36/539: | . . . . Scutellaria (skullcap) | |
A61K36/54: | . . . Lauraceae (Laurel family), e.g. cinnamon or sassafras | |
A61K36/55: | . . . Linaceae (Flax family), e.g. Linum | |
A61K36/56: | . . . Loganiaceae (Logania family), e.g. trumpetflower or pinkroot | |
A61K36/57: | . . . Magnoliaceae (Magnolia family) | |
A61K36/575: | . . . . Magnolia | |
A61K36/58: | . . . Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem) | |
A61K36/59: | . . . Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead | |
A61K36/60: | . . . Moraceae (Mulberry family), e.g. breadfruit or fig | |
A61K36/605: | . . . . Morus (mulberry) | |
A61K36/61: | . . . Myrtaceae (Myrtle family), e.g. teatree or eucalyptus | |
A61K36/62: | . . . Nymphaeaceae (Water-lily family) | |
A61K36/63: | . . . Oleaceae (Olive family), e.g. jasmine, lilac or ash tree | |
A61K36/634: | . . . . Forsythia | |
A61K36/638: | . . . . Ligustrum, e.g. Chinese privet | |
A61K36/64: | . . . Orobanchaceae (Broom-rape family) | |
A61K36/65: | . . . Paeoniaceae (Peony family), e.g. Chinese peony | |
A61K36/66: | . . . Papaveraceae (Poppy family), e.g. bloodroot | |
A61K36/67: | . . . Piperaceae (Pepper family), e.g. Jamaican pepper or kava | |
A61K36/68: | . . . Plantaginaceae (Plantain Family) | |
A61K36/69: | . . . Polygalaceae (Milkwort family) | |
A61K36/70: | . . . Polygonaceae (Buckwheat family), e.g. spineflower or dock | |
A61K36/704: | . . . . Polygonum, e.g. knotweed | |
A61K36/708: | . . . . Rheum (rhubarb) | |
A61K36/71: | . . . Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal | |
A61K36/714: | . . . . Aconitum (monkshood) | |
A61K36/716: | . . . . Clematis (leather flower) | |
A61K36/718: | . . . . Coptis (goldthread) | |
A61K36/72: | . . . Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree | |
A61K36/725: | . . . . Ziziphus, e.g. jujube | |
A61K36/73: | . . . Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn | |
A61K36/732: | . . . . Chaenomeles, e.g. flowering quince | |
A61K36/734: | . . . . Crataegus (hawthorn) | |
A61K36/736: | . . . . Prunus, e.g. plum, cherry, peach, apricot or almond | |
A61K36/738: | . . . . Rosa (rose) | |
A61K36/739: | . . . . Sanguisorba (burnet) | |
A61K36/74: | . . . Rubiaceae (Madder family) | |
A61K36/744: | . . . . Gardenia | |
A61K36/746: | . . . . Morinda | |
A61K36/748: | . . . . Oldenlandia or Hedyotis | |
A61K36/75: | . . . Rutaceae (Rue family) | |
A61K36/752: | . . . . Citrus, e.g. lime, orange or lemon | |
A61K36/754: | . . . . Evodia | |
A61K36/756: | . . . . Phellodendron, e.g. corktree | |
A61K36/758: | . . . . Zanthoxylum, e.g. pricklyash | |
A61K36/76: | . . . Salicaceae (Willow family), e.g. poplar | |
A61K36/77: | . . . Sapindaceae (Soapberry family), e.g. lychee or soapberry | |
A61K36/78: | . . . Saururaceae (Lizard's-tail family) | |
A61K36/79: | . . . Schisandraceae (Schisandra family) | |
A61K36/80: | . . . Scrophulariaceae (Figwort family) | |
A61K36/804: | . . . . Rehmannia | |
A61K36/808: | . . . . Scrophularia (figwort) | |
A61K36/81: | . . . Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed | |
A61K36/815: | . . . . Lycium (desert-thorn) | |
A61K36/82: | . . . Theaceae (Tea family), e.g. camellia | |
A61K36/83: | . . . Thymelaeaceae (Mezereum family), e.g. leatherwood or false ohelo | |
A61K36/835: | . . . . Aquilaria | |
A61K36/84: | . . . Valerianaceae (Valerian family), e.g. valerian | |
A61K36/85: | . . . Verbenaceae (Verbena family) | |
A61K36/855: | . . . . Clerodendrum, e.g. glorybower | |
A61K36/86: | . . . Violaceae (Violet family) | |
A61K36/87: | . . . Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine | |
A61K36/88: | . . Liliopsida (monocotyledons) | |
A61K36/882: | . . . Acoraceae (Calamus family), e.g. sweetflag or Acorus calamus | |
A61K36/884: | . . . Alismataceae (Water-plantain family) | |
A61K36/886: | . . . Aloeaceae (Aloe family), e.g. aloe vera | |
A61K36/888: | . . . Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage | |
A61K36/8884: | . . . . Arisaema, e.g. Jack in the pulpit | |
A61K36/8888: | . . . . Pinellia | |
A61K36/889: | . . . Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto | |
A61K36/8895: | . . . . Calamus, e.g. rattan | |
A61K36/89: | . . . Cyperaceae (Sedge family) | |
A61K36/8905: | . . . . Cyperus (flatsedge) | |
A61K36/894: | . . . Dioscoreaceae (Yam family) | |
A61K36/8945: | . . . . Dioscorea, e.g. yam, Chinese yam or water yam | |
A61K36/896: | . . . Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus | |
A61K36/8962: | . . . . Allium, e.g. garden onion, leek, garlic or chives | |
A61K36/8964: | . . . . Anemarrhena | |
A61K36/8965: | . . . . Asparagus, e.g. garden asparagus or asparagus fern | |
A61K36/8966: | . . . . Fritillaria, e.g. checker lily or mission bells | |
A61K36/8967: | . . . . Lilium, e.g. tiger lily or Easter lily | |
A61K36/8968: | . . . . Ophiopogon (Lilyturf) | |
A61K36/8969: | . . . . Polygonatum (Solomon's seal) | |
A61K36/898: | . . . Orchidaceae (Orchid family) | |
A61K36/8984: | . . . . Dendrobium | |
A61K36/8988: | . . . . Gastrodia | |
A61K36/899: | . . . Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane | |
A61K36/8994: | . . . . Coix (Job's tears) | |
A61K36/8998: | . . . . Hordeum (barley) | |
A61K36/90: | . . . Smilacaceae (Catbrier family), e.g. greenbrier or sarsaparilla | |
A61K36/902: | . . . Sparganiaceae (Bur-reed family) | |
A61K36/904: | . . . Stemonaceae (Stemona family), e.g. croomia | |
A61K36/906: | . . . Zingiberaceae (Ginger family) | |
A61K36/9062: | . . . . Alpinia, e.g. red ginger or galangal | |
A61K36/9064: | . . . . Amomum, e.g. round cardamom | |
A61K36/9066: | . . . . Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger | |
A61K36/9068: | . . . . Zingiber, e.g. garden ginger | |
A61K38/00: | Medicinal preparations containing peptides | |
A61K38/01: | . Hydrolysed proteins; Derivatives thereof | |
A61K38/02: | . Peptides of undefined number of amino acids; Derivatives thereof | |
A61K38/03: | . Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof | |
A61K38/04: | . Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof | |
A61K38/05: | . . Dipeptides | |
A61K38/06: | . . Tripeptides | |
A61K38/07: | . . Tetrapeptides | |
A61K38/08: | . . Peptides having 5 to 11 amino acids | |
A61K38/09: | . . . Luteinising hormone-releasing hormone (LHRH); Related peptides | |
A61K38/10: | . . Peptides having 12 to 20 amino acids | |
A61K38/11: | . . . Oxytocins; Vasopressins; Related peptides | |
A61K38/12: | . . Cyclic peptides | |
A61K38/13: | . . . Cyclosporins | |
A61K38/14: | . . Peptides containing saccharide radicals; Derivatives thereof | |
A61K38/15: | . . Depsipeptides; Derivatives thereof | |
A61K38/16: | . Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof | |
A61K38/17: | . . from animals; from humans | |
A61K38/18: | . . . Growth factors; Growth regulators | |
A61K38/19: | . . . Cytokines; Lymphokines; Interferons | |
A61K38/20: | . . . . Interleukins | |
A61K38/21: | . . . . Interferons | |
A61K38/22: | . . . Hormones | |
A61K38/23: | . . . . Calcitonins | |
A61K38/24: | . . . . Follicle-stimulating hormone (FSH); Chorionic gonadotropins, e.g. HCG; Luteinising hormone (LH); Thyroid-stimulating hormone (TSH) | |
A61K38/25: | . . . . Growth hormone-releasing factor (GH-RF) (Somatoliberin) | |
A61K38/26: | . . . . Glucagons | |
A61K38/27: | . . . . Growth hormone (GH) (Somatotropin) | |
A61K38/28: | . . . . Insulins | |
A61K38/29: | . . . . Parathyroid hormone (parathormone); Parathyroid hormone-related peptides | |
A61K38/30: | . . . . Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2 | |
A61K38/31: | . . . . Somatostatins | |
A61K38/32: | . . . . Thymopoietins | |
A61K38/33: | . . . derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin | |
A61K38/34: | . . . . Melanocyte stimulating hormone (MSH), e.g. alpha- or beta-melanotropin | |
A61K38/35: | . . . . Corticotropin (ACTH) | |
A61K38/36: | . . . Blood coagulation or fibrinolysis factors | |
A61K38/37: | . . . . Factors VIII | |
A61K38/38: | . . . Albumins | |
A61K38/39: | . . . Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin (CIG) | |
A61K38/40: | . . . Transferrins, e.g. lactoferrins, ovotransferrins | |
A61K38/41: | . . Porphyrin- or corrin-ring-containing peptides | |
A61K38/42: | . . . Haemoglobins; Myoglobins | |
A61K38/43: | . . Enzymes; Proenzymes; Derivatives thereof | |
A61K38/44: | . . . Oxidoreductases (1) | |
A61K38/45: | . . . Transferases (2) | |
A61K38/46: | . . . Hydrolases (3) | |
A61K38/47: | . . . . acting on glycosyl compounds (3.2), e.g. cellulases, lactases | |
A61K38/48: | . . . . acting on peptide bonds (3.4) | |
A61K38/49: | . . . . . Urokinase; Tissue plasminogen activator | |
A61K38/50: | . . . . acting on carbon-nitrogen bonds, other than peptide bonds (3.5), e.g. asparaginase | |
A61K38/51: | . . . Lyases (4) | |
A61K38/52: | . . . Isomerases (5) | |
A61K38/53: | . . . Ligases (6) | |
A61K38/54: | . . . Mixtures of enzymes or proenzymes covered by more than a single one of groups or | |
A61K38/55: | . . Protease inhibitors | |
A61K38/56: | . . . from plants | |
A61K38/57: | . . . from animals; from humans | |
A61K38/58: | . . . . from leeches, e.g. hirudin, eglin | |
A61K39/00: | Medicinal preparations containing antigens or antibodies | |
A61K39/002: | . Protozoa antigens | |
A61K39/005: | . . Trypanosoma antigens | |
A61K39/008: | . . Leishmania antigens | |
A61K39/012: | . . Coccidia antigens | |
A61K39/015: | . . Hemosporidia antigens, e.g. Plasmodium antigens | |
A61K39/018: | . . . Babesia antigens, e.g. Theileria antigens | |
A61K39/02: | . Bacterial antigens | |
A61K39/04: | . . Mycobacterium, e.g. Mycobacterium tuberculosis | |
A61K39/05: | . . Corynebacterium; Propionibacterium | |
A61K39/07: | . . Bacillus | |
A61K39/08: | . . Clostridium, e.g. Clostridium tetani | |
A61K39/085: | . . Staphylococcus | |
A61K39/09: | . . Streptococcus | |
A61K39/095: | . . Neisseria | |
A61K39/10: | . . Brucella; Bordetella, e.g. Bordetella pertussis | |
A61K39/102: | . . Pasteurella; Haemophilus | |
A61K39/104: | . . Pseudomonas | |
A61K39/106: | . . Vibrio; Campylobacter | |
A61K39/108: | . . Escherichia; Klebsiella | |
A61K39/112: | . . Salmonella; Shigella | |
A61K39/114: | . . Fusobacterium | |
A61K39/116: | . . Polyvalent bacterial antigens | |
A61K39/118: | . Chlamydiaceae, e.g. Chlamydia trachomatis or Chlamydia psittaci | |
A61K39/12: | . Viral antigens | |
A61K39/125: | . . Picornaviridae, e.g. calicivirus | |
A61K39/13: | . . . Poliovirus | |
A61K39/135: | . . . Foot-and-mouth disease virus | |
A61K39/145: | . . Orthomyxoviridae, e.g. influenza virus | |
A61K39/15: | . . Reoviridae, e.g. calf diarrhea virus | |
A61K39/155: | . . Paramyxoviridae, e.g. parainfluenza virus | |
A61K39/165: | . . . Mumps or measles virus | |
A61K39/17: | . . . Newcastle disease virus | |
A61K39/175: | . . . Canine distemper virus | |
A61K39/187: | . . Hog cholera virus | |
A61K39/193: | . . Equine encephalomyelitis virus | |
A61K39/20: | . . Rubella virus | |
A61K39/205: | . . Rhabdoviridae, e.g. rabies virus | |
A61K39/21: | . . Retroviridae, e.g. equine infectious anemia virus | |
A61K39/215: | . . Coronaviridae, e.g. avian infectious bronchitis virus | |
A61K39/225: | . . . Porcine transmissible gastroenteritis virus | |
A61K39/23: | . . Parvoviridae, e.g. feline panleukopenia virus | |
A61K39/235: | . . Adenoviridae | |
A61K39/245: | . . Herpetoviridae, e.g. herpes simplex virus | |
A61K39/25: | . . . Varicella-zoster virus | |
A61K39/255: | . . . Marek's disease virus | |
A61K39/265: | . . . Infectious rhinotracheitis virus | |
A61K39/27: | . . . Equine rhinopneumonitis virus | |
A61K39/275: | . . Poxviridae, e.g. avipoxvirus | |
A61K39/285: | . . . Vaccinia virus or variola virus | |
A61K39/29: | . . Hepatitis virus | |
A61K39/295: | . . Polyvalent viral antigens; Mixtures of viral and bacterial antigens | |
A61K39/35: | . Allergens | |
A61K39/36: | . . from pollen | |
A61K39/38: | . Antigens from snakes | |
A61K39/385: | . Haptens or antigens, bound to carriers | |
A61K39/39: | . characterised by the immunostimulating additives, e.g. chemical adjuvants | |
A61K39/395: | . Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum | |
A61K39/40: | . . bacterial | |
A61K39/42: | . . viral | |
A61K39/44: | . . Antibodies bound to carriers | |
A61K41/00: | Medicinal preparations obtained by treating materials with wave energy or particle radiation | |
A61K45/00: | Medicinal preparations containing active ingredients not provided for in groups | |
A61K45/06: | . Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca | |
A61K45/08: | . Mixtures of an active ingredient and an auxiliary substance neither being chemically characterised, e.g. antihistaminicum and surface active substance | |
A61K47/00: | Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient | |
A61K47/02: | . Inorganic compounds | |
A61K47/04: | . . Non-metals; Compounds thereof | |
A61K47/06: | . Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite | |
A61K47/08: | . . containing oxygen | |
A61K47/10: | . . . Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers | |
A61K47/12: | . . . Carboxylic acids; Salts or anhydrides thereof | |
A61K47/14: | . . . Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters | |
A61K47/16: | . . containing nitrogen | |
A61K47/18: | . . . Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids | |
A61K47/20: | . . containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids | |
A61K47/22: | . . Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones | |
A61K47/24: | . . containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids | |
A61K47/26: | . . Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin | |
A61K47/28: | . . Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid | |
A61K47/30: | . Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates | |
A61K47/32: | . . Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers | |
A61K47/34: | . . Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers | |
A61K47/36: | . . Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin | |
A61K47/38: | . . . Cellulose; Derivatives thereof | |
A61K47/40: | . . . Cyclodextrins; Derivatives thereof | |
A61K47/42: | . . Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein | |
A61K47/44: | . Oils, fats or waxes according to two or more groups of ; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin | |
A61K47/46: | . Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts | |
A61K47/48: | . the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates | |
A61K47/50: | . the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates | |
A61K47/51: | . . the non-active ingredient being a modifying agent | |
A61K47/52: | . . . the modifying agent being an inorganic compound, e.g. an inorganic ion that is complexed with the active ingredient | |
A61K47/54: | . . . the modifying agent being an organic compound | |
A61K47/55: | . . . . the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds | |
A61K47/56: | . . . the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule | |
A61K47/58: | . . . . obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin | |
A61K47/59: | . . . . obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes | |
A61K47/60: | . . . . . the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol | |
A61K47/61: | . . . . the organic macromolecular compound being a polysaccharide or a derivative thereof | |
A61K47/62: | . . . the modifying agent being a protein, peptide or polyamino acid | |
A61K47/64: | . . . . Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent | |
A61K47/65: | . . . . Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers | |
A61K47/66: | . . . . the modifying agent being a pre-targeting system involving a peptide or protein for targeting specific cells | |
A61K47/68: | . . . the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment | |
A61K47/69: | . . the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit | |
A61K48/00: | Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy | |
A61K49/00: | Preparations for testing in vivo | |
A61K49/04: | . X-ray contrast preparations | |
A61K49/06: | . Nuclear magnetic resonance (NMR) contrast preparations; Magnetic resonance imaging (MRI) contrast preparations | |
A61K49/08: | . . characterised by the carrier | |
A61K49/10: | . . . Organic compounds | |
A61K49/12: | . . . . Macromolecular compounds | |
A61K49/14: | . . . . Peptides, e.g. proteins | |
A61K49/16: | . . . . . Antibodies; Immunoglobulins; Fragments thereof | |
A61K49/18: | . . characterised by a special physical form, e.g. emulsions, microcapsules, liposomes | |
A61K49/20: | . . containing free radicals | |
A61K49/22: | . Echographic preparations; Ultrasound imaging preparations | |
A61K50/00: | Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ECG) or for transcutaneous drug administration | |
A61K51/00: | Preparations containing radioactive substances for use in therapy or testing in vivo | |
A61K51/02: | . characterised by the carrier | |
A61K51/04: | . . Organic compounds | |
A61K51/06: | . . . Macromolecular compounds | |
A61K51/08: | . . . Peptides, e.g. proteins | |
A61K51/10: | . . . . Antibodies or immunoglobulins; Fragments thereof | |
A61K51/12: | . characterised by a special physical form, e.g. emulsion, microcapsules, liposomes | |
A61K101/00: | Radioactive non-metals | |
A61K101/02: | . Halogens | |
A61K103/00: | Radioactive metals | |
A61K103/10: | . Technetium; Rhenium | |
A61K103/20: | . Indium | |
A61K103/30: | . Rare earths | |
A61K103/32: | . . Yttrium | |
A61K103/34: | . . Gadolinium | |
A61K103/36: | . . Ytterbium | |
A61K103/40: | . Actinides | |
A61K125/00: | Containing or obtained from roots, bulbs, tubers, corms or rhizomes | |
A61K127/00: | Containing or obtained from leaves | |
A61K129/00: | Containing or obtained from bark | |
A61K131/00: | Containing or obtained from seeds, nuts, fruits or grains | |
A61K133/00: | Containing or obtained from flowers or blossoms | |
A61K135/00: | Containing or obtained from stems, stalks, branches, twigs or shoots | |